Daily as of 3 Nov 16:00 ET
- Price
- between the two $55.00 vs 50 $57.35 / 200 $45.72
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 28 Aug 2025 ยท projected 19 bars out ยท tested 2 bars
MBX Biosciences (MBX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2025.
The 50 SMA has sat above the 200 on the daily since Aug 2025, with no cross projected inside the 30 bars Cruxta tracks. Price sits between the 50 and the 200 on the daily and the 4-hour.
No weekly data
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 20 Oct 2026 | ๐Death | 4-hour | 27 bars out | 1 bar cross test |
| 28 Aug 2025 | ๐จGolden flat | daily | 19 bars out | 2 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.